medigraphic.com

2003, Number 1

<< Back Next >>

Arch Cardiol Mex 2003; 73 (1)

Study of the relation between the electromolecular characteristics of digitalis compounds and their pharmacological action

Del Valle ML, Torres NJC, Zarco OG, Tenorio LFA, Pastelín HG

Language: Spanish
References: 33
Page: 11-17
PDF size: 149.15 Kb.


ABSTRACT

In spite their reduced therapeutic index, digitalis-type drugs continue being used for treating diseases such as congestive heart failure and chronic atrial fibrillation. Thanks to the development of several methods, their structural determination has been feasible, so, structural modifications have been worked out to modulate their toxicity. Several reports realizes that efficacy for these digitalis-type drugs lies on the electronegativity centered on the steroidal moiety (D-ring) generated by either lactone and hydroxyl substituents attached to the steroidal moiety. In this work, we report how electronegativity, and so structural conformation, does modify their pharmacological properties, e.g., inotropism and safety margin. Thus, we evaluated a series of eleven drugs derived from digitoxigenin, named -OH, -Lac, D-01, D-02, D-03, D-07, D-14, D-15, D-20, D-21 and D-22, with groups that substitute both lactone and hydroxyl groups on the steroidal D-ring. Electronegativity and conformational energy were determined by Duhamm’s method. The pharmacological evaluation for these drugs was accomplished in guinea pigs isolated hearts (according to the model proposed by Langendorff) and dog’s isolated heart (as established by Starling’s in vivo model). The results may suggest that digitalis-like action lies on the substituents attached to the D-ring. Positive inotropic effect and therapeutic index are related with increases in electronegativity as well with decreases in rotational and traslational energies; therefore, these molecular properties have such importance for the digitalis efficacy.


REFERENCES

  1. Mendez R: Doscientos años de digital. Arch Inst Cardiol Mex 1986; 56: 339-348.

  2. Tischler M, Smith T: Digitalis: its current place in the treatment of heart failure. Modern Conc Cardiovasc Dis 1990; 59: 67-72.

  3. Hoffman B, Bigger J: Digital y otros glucósidos cardiacos relacionados. En: Goodman A, Rall T, Nies A, Taylor P. editores. Goodman y Gilman: Las Bases Farmacológicas de la Terapéutica. 8ª Ed. México. Editorial Médica Panamericana, 1991, p 794-818.

  4. Pastelín G, Méndez R: Glucósidos cardiacos y otros fármacos inotrópicos positivos. En: Velasco A, Lorenzo P, Serrano J S, Andres-Trelles F. editores. Velázquez: Farmacología. 16ª Ed. Barcelona. Editorial Interamericana, McGraw-Hill, 1993. p 530-544.

  5. The digitalis investigation group: The effect of digoxin on mortality and morbidity in patients with heart failure. New Engl J Med 1997; 336: 525-533.

  6. Fieser L, Fieser M: Steroids. New York. Reinhold Publishing Co., 1959. p 24-35, 67-79.

  7. Ramshar M, Volkar J: Biomedical Pharmacology. London. Harper & Row, Publishers, 1989. p 388-441, 510, 571-579.

  8. Wiesner K, Tsai T: Some recent progress in the synthetic and medicinal chemistry of cardioactive steroid glycosides. Pure Appl Chem 1986; 58: 799-810.

  9. O’Maller R, Potter S: Molecular structure and pharmacology. 2a Ed. Ottawa. Jowhelleth Co., 1983. p 30-46, 80-110, 256-279, 435-437, 450.

  10. Bevan J: Essentials of pharmacology. Introduction to the principles of drugs action. 3ª Ed. London. Harper & Row Publishers, 1986. p 60-75, 90-93.

  11. Helm H, Backenfeld T, Muller B, Waaler T: Electroverneinend aufbave bei steroiden. Helv Chim Acta 1985; 68: 300-314. p 24-26, 68-71, 114-116, 135-137, 245, 268, 381-390.

  12. Deghenghi Romano: Synthetic Cardenolides and Related Products. Pure Appl Chem 1970; 21: 153-165.

  13. Pastelin G, Mendez R: The Influence of a Methyl Group in the Cardiac Activity of the Semisynthetic Glicoside Glucodigitoxigenin. Arch Pharm Tox 1984; X: 135-141.

  14. Wiesner K and Tsai T: Some Recent Progress in the Synthetic and Medicinal Chemistry of Cardioactive Steroid Glycosides. Pure Appl Chem 1986; 58(5): 799-810.

  15. Garcia-Domenech R, Galvez J: Molecular Topology: Its Role in the Design of New Drugs. Invest Sci (Sci Am, Spanish Edition) 1993; 2(2): 86-87.

  16. Feigl F, Anger V: Pruebas a la gota en análisis orgánico. México. El Manual Moderno, 1978. p 75, 78, 92, 103-107, 200-211, 222, 243-245.

  17. Tatsime-Ohi K, Hiyamoto Y: Functional analysis. New York. Shendo, 1989. p 7-51, 90-102.

  18. Shriner R, Fuson R, Curtin D, Morrill T: The systematic identification of organic compounds. 6ª Ed. Toronto. John Wiley and Sons, 1979. p 42-42, 46-49, 78-91, 133-140, 248-260.

  19. Castellanos J: Avances en análisis de esteroides. 2ª Ed. Lisboa. Editorial Científica-Médica, 1973. p 1-155, 289-301.

  20. Siggia S: Quantitative Organic Analysis via Functional Groups. 4a Ed. New York. John Wiley and Sons, 1996. p 45-77, 90-121.

  21. Simmans Co: Spectrophotometric assay. 2ª Ed. New Jersey. Simmans Public, 1980. p 71-92.

  22. Lemmedt T, Klauss W: The nuclear magnetic resonance in the pharmacology. Philadelphia. Sonth-Hill, 1980. p 1-89, 160-201.

  23. Kiwalth R, Kimari O: Start of the Nuclear Magnetic Resonance. New York. D’Evan Nostrand, 1988. p 34-45, 57, 78, 109, 200-203.

  24. Ciurczak EW, Drennen JK: Pharmaceutical and Medical Applications of Near-Infrared Spectroscopy. 2ª Ed. New York. Marcel Dekker, 2002. P 56-78, 100-139, 165-170.

  25. Döring H, Dehnert H: The isolated perfused heart according to Langendorff. Friburgo de Brisgovia, Biomesstechnik-Verlag, 1988. p 1-70.

  26. Box G, Hunter W: Estadística para Investigadores: Introducción al Diseño de Experimentos, Análisis de Datos y Construcción de Modelos. 3a Ed. México. Reverté, 1999. p 345-580.

  27. Mendez R, Pastelín G, Kabela E: The influence of the position of attachment of the lactone ring to the steroid nucleus on the action of the cardiac glycosides. J Pharmacol Exp Ther 1974; 188: 189-197.

  28. Galvez J, Garcia-Domenech R, Julian-Ortiz JV, Soler R: Topological Approach to Drug Design. J Chem Inf Comput Sci 1995; 35: 272-284.

  29. Galvez J: On a topological interpretation of electronic and vibrational molecular energies. J Mol Struc (Theochem) 1998; 429: 255-264.

  30. Galvez J, Garcia-Domenech R, de Julian-Ortiz JV: Some Relationships between Molecular Energy-Topology and Symmetry. En: Carbo-Dorca A. eds. Kuwer Academic: Fundamentals of Molecular Similarity, New York. Plenum Publishers, 2001, p 11-31.

  31. Tokuyama TJ, et al: The Structure of Batrachotoxin A, a Noves Steroidal Alkaloid from the Colombian Arrow Poison Frog. J Am Chem Soc 1968; 90: 917-918.

  32. Jahr EAK, et al: Ueber die Herzwirkung Einfacher Bisguanylhydrazone, Arzneimittel-Forsch. Arch Exp Pathol Pharm 1964; 14: 273-277.

  33. Wasserstrom JA, Farkas D, Norell M, Vereault DV: Effects of Different Cardiac Steroids on Intracellular Sodium Inotropy and Toxicity in Sheep Purkinje Fibers. J Pharmacol Exp Ther 1991; 258: 918-925.




2020     |     www.medigraphic.com